Table 2.
Preferred treatment modality | Percentage response |
---|---|
Ultrasound | 59 %* |
Ultrasound plus luteal phase progesterone measurement | 14 % |
Ultrasound plus Estrogen plus luteal phase progesterone measurement | 15 % |
Luteal phase progesterone measurement | 6 % |
No monitoring | 5 % |
*Response that was significantly higher (p < 0.05) than all other individual answer choices